These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13728586)

  • 1. [Phospholipids in the erythrocytes in arteriosclerosis].
    NEUWIRTOVA R; DONNER L; HEYROVSKY A; VOPATOVA M
    Sb Lek; 1960 Dec; 62():358-64. PubMed ID: 13728586
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of serum phospholipids and proteins in arteriosclerosis].
    VULTERINI S
    Prog Med (Napoli); 1953 Oct; 9(20):617-27. PubMed ID: 13121112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin-induced changes in relation to the total cholesterol/phospholipid ratio in normal subjects and in arteriosclerosis patients].
    GUARINI G
    Boll Soc Ital Biol Sper; 1956; 32(7-8):724-5. PubMed ID: 13404117
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative analysis of the phospholipid fractions in normal senescence and in senile arteriosclerosis].
    Vitelli A; Piancino G; Martini PF
    G Gerontol; 1966 Dec; 14(12):1151-3. PubMed ID: 5992335
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chromatographic study of plasma and erythrocyte phospholipids after an oral load of animal phospholipids].
    Ferlito S; Lo Furno F; Fichera C; Terranova R
    Arch Maragliano Patol Clin; 1973 Jan; 29(1):51-62. PubMed ID: 4801939
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of phospholipids in human thrombocytes and erythrocytes.
    BLOMSTRAND R; NAKAYAMA F; NILSSON IM
    J Lab Clin Med; 1962 May; 59():771-8. PubMed ID: 13870104
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative chromatographic analysis of the phospholipids of abnormal human red blood cells.
    PHILLIPS GB; ROOME NS
    Proc Soc Exp Biol Med; 1962 Feb; 109():360-4. PubMed ID: 14486235
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective adsorption of disaturated phospholipids and risk of atherosclerosis.
    Nutr Rev; 1980 Apr; 38(4):142-3. PubMed ID: 7207877
    [No Abstract]   [Full Text] [Related]  

  • 9. The high-performance liquid chromatographic analysis for the peroxidized phospholipids in equine erythrocytes and skeletal muscle.
    Matsuki N; Tamura S; Ono K; Watari T; Goitsuka R; Takagi S; Hasegawa A
    J Vet Med Sci; 1991 Aug; 53(4):717-9. PubMed ID: 1834215
    [No Abstract]   [Full Text] [Related]  

  • 10. Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: comparison with plasma phospholipids.
    Vlaardingerbroek H; Hornstra G
    Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):363-74. PubMed ID: 15519495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane lipids and protein-bound carbohydrates status during the maturation of reticulocytes to erythrocytes in type 2 diabetics.
    Sailaja YR; Baskar R; Srinivas Rao CS; Saralakumari D
    Clin Chim Acta; 2004 Mar; 341(1-2):185-92. PubMed ID: 14967175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma phosphatidylethanolamine--a better indicator in the predictability of atherosclerotic complications?
    Kunz F; Stummvoll W
    Atherosclerosis; 1971; 13(3):413-25. PubMed ID: 5119241
    [No Abstract]   [Full Text] [Related]  

  • 13. [The nervous system and arteriosclerosis].
    GANELINA Ie; IL'INSKII BV
    Arkh Patol; 1960; 22(11)():5-13. PubMed ID: 13703330
    [No Abstract]   [Full Text] [Related]  

  • 14. The electrophoretic mobility of erythrocytes as a measure of the surface activity of plasma from patients with and without evidence of atheroma.
    DAVIES DF
    Clin Sci; 1958 Nov; 17(4):563-73. PubMed ID: 13608966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of inactivation of RU inhibitor (the inhibitor in the supernatant of reticulocyte hemolysates) between stroma and phosphatides of erythrocytes].
    RAPOPORT S; GERISCHER-MOTHES W
    Acta Biol Med Ger; 1959; 2(3):313-20. PubMed ID: 13660656
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous blood cholesterol and phospholipid correction in atherosclerosis.
    NELSON AM
    Trans Am Coll Cardiol; 1955 Apr; 4():235-6. PubMed ID: 14373776
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
    De Castro J; Hernández-Hernández A; Rodríguez MC; Sardina JL; Llanillo M; Sánchez-Yagüe J
    Platelets; 2007 Feb; 18(1):43-51. PubMed ID: 17365853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythrocyte concentrations of adenosine triphosphate (ATP) and magnesium, before and after conservative therapy of lower extremities atherosclerosis].
    Drozdz W; Kedryna T; Ostrowska B; Wilczek M; Stachurska B
    Pol Merkur Lekarski; 2004 Apr; 16(94):332-6. PubMed ID: 15517927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythrocyte premeability in hypertension and atherosclerosis].
    BEREZOVSKII BS
    Ter Arkh; 1957 Nov; 29(11):38-42. PubMed ID: 13543773
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections.
    Ishii F; Nagasaka Y
    Colloids Surf B Biointerfaces; 2004 Aug; 37(1-2):43-7. PubMed ID: 15450307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.